Contact us
Menu
Contact us

Feldan News

on May 29,2018

QUEBEC CITY, May 29, 2018 - Feldan Therapeutics, Inc. announced today the issuance of a new patent related to the refinement of the Feldan Shuttle platform. This technology, a peptide-based …

Read Story

on May 1,2018

Feldan Therapeutics’ Research Director, Dr. David Guay, will be attending TIDES: Oligonucleotides and Peptide Therapeutics Conference next week, May 7-10th at Hynes Convention Center in Boston. Come to chat with …

Read Story